Basit öğe kaydını göster

dc.contributor.authorAlharbi, Wejdan Alhumaidi A.
dc.contributor.authorAlmadi, Ebtesam Ali S.
dc.contributor.authorAlwabisi, Shoog Abdullah O.
dc.contributor.authorAlbalawi, Nashwa Zead A.
dc.contributor.authorAlanazi, Hamdah Hnef S.
dc.contributor.authorAlthobaiti, Alanoud Abdullah H.
dc.contributor.authorAlkhathami, Amirah Ali M.
dc.contributor.authorAlamrani, Amani Salem K.
dc.contributor.authorAltemani, Omniah Salem D.
dc.contributor.authorMohammedsaleh, Maani Mahmoud A.
dc.contributor.authorAljuhani, Arwa Mohammed Alrefai
dc.contributor.authorAlrashidi, Rinad Rasheed M.
dc.contributor.authorIbrahim, Ahmed Abdulaziz G.
dc.contributor.authorAlMutairi, Mazyad Hamed M.
dc.contributor.authorALMutairi, Abeer Fahad M.
dc.date.accessioned2022-02-18T10:39:28Z
dc.date.available2022-02-18T10:39:28Z
dc.date.issued2021
dc.identifier.citationIbrahim A. A. G. , AlMutairi M. H. M. , ALMutairi A. F. M. , Alharbi W. A. A. , Almadi E. A. S. , Alwabisi S. A. O. , Albalawi N. Z. A. , Alanazi H. H. S. , Althobaiti A. A. H. , Alkhathami A. A. M. , et al., "Updated Treatment of Fibromyalgia Syndrome: A Review", JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, cilt.33, sa.52B, ss.72-79, 2021
dc.identifier.othervv_1032021
dc.identifier.otherav_b00bf9a2-be34-4ef6-b44e-69cc87e91cd8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179642
dc.identifier.urihttps://doi.org/10.9734/jpri/2021/v33i52b33601
dc.description.abstractFibromyalgia is a debilitating condition that is frequently misdiagnosed. It affects 2% of the population, with middle-aged women having the highest frequency. Fibromyalgia affects more women than men, and It becomes worse as you get older. Because medical treatment for fibromyalgia is typically only partial, health professionals must provide patients with ongoing assistance in order for them to become effective, active self-managers. There is no one-size-fits-all drug for fibromyalgia, but you do have a lot of options for treating your symptoms. However, Antidepressants in general such as "duloxetine" and Gabapentinoids drugs such as "pregabline" are the most used drugs. There is some evidence that NSAIDs may have a synergistic effect when combined with centrally active agents such as tricyclic antidepressants and anticonvulsants. Among non-pharmacological therapy, exercise and psychoeducational techniques have the most evidence of efficacy, but they must be personalized to the individual. In this review we will be looking at diagnosis and treatment of fibromyalgia.
dc.language.isoeng
dc.subjectPharmacy
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectPharmacology (medical)
dc.subjectDrug Guides
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.titleUpdated Treatment of Fibromyalgia Syndrome: A Review
dc.typeMakale
dc.relation.journalJOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL
dc.contributor.departmentKing Salman Mil Hosp , ,
dc.identifier.volume33
dc.identifier.issue52B
dc.identifier.startpage72
dc.identifier.endpage79
dc.contributor.firstauthorID2774085


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster